NCT00274027View on ClinicalTrials.gov

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

tiotropium bromide

Trial Locations (1)

K7L 2V6

Kingston General Hospital, Kingston

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00274027 - Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) | Biotech Hunter | Biotech Hunter